Free Shipping on U.S. Orders Over $35 100% Satisfaction Guarantee

Probiotic+

with prebiotics and zinc carnosine

Probiotic+

with prebiotics and zinc carnosine

The first probiotic designed for athletes. Exercise places unique stress on the gut mucosa. Probiotic+ with Zinc Carnosine is specifically formulated to provide greater support for an athlete’s gut than probiotics alone. Gut health leads to better recovery, immunity, mental function, and physical function. A healthy body starts with a healthy gut.*

 The first Probiotic plus Zinc-Carnosine, plus Prebiotic formulated to support the unique gut health needs of the athlete.

  • Enhance athletic recovery*
  • Support intestinal health, gut lining integrity, and less gut inflammation*
  • Support gut mediated immunity and nutrient absorption*
  • Provide cardiovascular support*
  • Promote hormonal and sexual health in both men & women*

free shipping & 100% satisfaction guarantee

How can Probiotic+ benefit you?

digestive health

Intense exercise places strain on the digestive tract. To help, Probiotic+ is formulated with microorganisms that support the stability and function of the digestive tract. This helps improve nutritional absorption and supports reduced gut inflammation. It also supports bowel regularity, lessens flatulence, and can improve milk tolerance.

intestinal barrier health

The gut lining is unique and critical to your health. It provides a barrier to pathogens and toxins while it absorbs nutrients. Unfortunately, intense exercise can impair the gut barrier, leading to slower athletic recovery. Probiotic+ is designed to support your gut lining stability and integrity to ensure maximum athletic performance.

immunity

Your gut bacteria play key roles in the production of antibodies and immune cell responses. Unfortunately, an athlete's gut-dependent immunity can be strained by excessive training and long seasons. This can negatively affect your general immunity and overall health. Probiotic+ provides your gut with more good bacterial strains that inhibit the growth of harmful gut bacteria, and promote the production of natural antibodies and immune cells. This helps your body fight viral, bacterial, and fungal pathogens.

Support for Men & Women

cardiovascular health

The higher calorie and protein diets that athletes require can affect lipid levels and long term cardiovascular health. Probiotic+ supports normal total cholesterol and LDL (bad cholesterol) levels by supporting proper cholesterol absorption in the intestines, and by supporting reduced excess cholesterol formation in the liver. Further, Probiotic+ supports the enzymes your body uses to metabolize fat and cholesterol.

men’s health

Athletes require a proper balance of stress hormones (cortisol), which are catabolic, and testosterone, which is anabolic. Intense exercise and long athletic seasons can increase your cortisol and impair your testosterone levels. Probiotic+ supports leydig cells, the testicular cells responsible for testosterone production. Probiotic+ also supports testicular sperm cell production. as well as also supporting testicular sperm cell production.

female health

Intense exercise can lead to the production of bacteria and yeast. Unfortunately, this means female athletes often experience vaginal itching, chafing, redness, sweating, discharge, painful urination, and strong odors. To counteract this, Probiotic+ supports vaginal health by helping balance vaginal flora (yeast and bacteria), and by supporting a healthy pH in the vagina. Probiotic+ can also help promote urinary tract health.

A Word From The Doctor

Why did you formulate this?

“Years of gut microbial study has revealed the stunning importance of normal gut flora, and how this is altered by the foods we eat, by our health conditions, and by our exercise habits. Athletes have unique requirements, and gut health plays an important role in their success. So we created a gut formulation designed to optimize gut health under the rigors of intense exercise.”

our ingredients

We use trial-proven ingredients at clinically-backed doses that produce measurable results. We never hide behind prop blends or label loopholes.

10 Probiotic Strains. 50 Billion CFU’s

  • 10% Lactobacillus salivarus LS97
  • 10% Lactobacillus casei LC89
  • 10% Lactobacillus rhamnosus LRao5
  • 10% Lactobacillus acidophilusLA85
  • 10% Lactobacillus plantarium Lp90
  • 10% Lactobacillus reuteri LRo8
  • 10% Bifidobacterium longum LB21
  • 10% Bifidobacterium lactis BLa8o
  • 10% Bifidobacterium breve BBr6o
  • 10% Bifidobacterium infantis BI45

Prebiotic

100mg inulin from chicory root

Zinc-Carnosine

75mg

suggested use

directions

Take 2 capsules once daily, 30 minutes to 1 hour before a meal to help optimize gut flora and gut support.

when to take it

Shelf stable so no refrigeration is required.
Keep in a cool, dry place.

FAQ's

Our standard serving size is 2 capsules. 2 capsules will provide you with 10 Probiotic strains (50 Billion CFU’s). It also provides 75mg of Zinc Carnosine and 100mg of Inulin (Prebiotics)

No. Probiotic+ is shelf stable meaning you do not have to refrigerate the product.

Yes. We recommend you take Probiotic+ 30 minutes to 1 hour before a meal to help optimize gut flora.

Probiotic+ should be taken daily. It can be taken with other vitamins or supplements.

Yes. Probiotic+ is produced in a GMP (Good Manufacturing Practice), state of the art facility to ensure quality and your safety.

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

references

1. Tinrat S, Saraya S, Traidej Chomnawang M. Isolation and characterization of Lactobacillus salivarius MTC 1026 as a potential probiotic. J Gen Appl Microbiol. 2011;57(6):365-78. doi: 10.2323/jgam.57.365. PMID: 22353742.

2. Lv LX, Yan R, Shi HY, Shi D, Fang DQ, Jiang HY, Wu WR, Guo FF, Jiang XW, Gu SL, Chen YB, Yao J, Li LJ. Integrated transcriptomic and proteomic analysis of the bile stress response in probiotic Lactobacillus salivarius LI01. J Proteomics. 2017 Jan 6;150:216-229. doi: 10.1016/j.jprot.2016.08.021. Epub 2016 Aug 30. PMID: 27585996.

3. Shimauchi H, Mayanagi G, Nakaya S, Minamibuchi M, Ito Y, Yamaki K, Hirata H. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol. 2008 Oct;35(10):897-905. doi: 10.1111/j.1600-051X.2008.01306.x. Epub 2008 Aug 24. PMID: 18727656.

4. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L, Shanahan F. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006 Jun;118(2):202-15. doi: 10.1111/j.1365-2567.2006.02358.x. PMID: 16771855; PMCID: PMC1782284.

5. Tatiana Colombo Pimentel, Larissa Ramalho Brandão, Matthaws Pereira de Oliveira, Whyara Karoline Almeida da Costa, Marciane Magnani, Health benefits and technological effects of Lacticaseibacillus casei-01: An overview of the scientific literature, Trends in Food Science & Technology, Volume 114, 2021, Pages 722-737, ISSN 0924-2244.

6. Gleeson M, Bishop NC, Struszczak L. Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial. Eur J Appl Physiol. 2016 Aug;116(8):1555-63. doi: 10.1007/s00421-016-3415-x. Epub 2016 Jun 13. PMID: 27294502; PMCID: PMC4943997.

7. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab. 2011 Feb;21(1):55-64. doi: 10.1123/ijsnem.21.1.55. PMID: 21411836.

8. Kazumasa Matsumoto, Toshihiko Takada, Kensuke Shimizu, Yukiko Kado, Koji Kawakami, Ikuyo Makino, Yoshitaku Yamaoka, Koichi Hirano, Akira Nishimura, Osami Kajimoto, Koji Nomoto, The Effects of a Probiotic Milk Product Containing Lactobacillus casei Strain Shirota on the Defecation Frequency and the Intestinal Microflora of Sub-optimal Health State Volunteers: A Randomized Placebo-controlled Cross-over Study, Bioscience and Microflora, 2006, Volume 25, Issue 2, Pages 39-48, Released May 24, 2006.

9. Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol. 2006 Apr;40(4):312-6. doi: 10.1097/01.mcg.0000210092.77296.6d. PMID: 16633103.

10. Yap WB, Ahmad FM, Lim YC, Zainalabidin S. Lactobacillus casei strain C1 attenuates vascular changes in spontaneously hypertensive rats. Korean J Physiol Pharmacol. 2016 Nov;20(6):621-628. doi: 10.4196/kjpp.2016.20.6.621. Epub 2016 Oct 28. PMID: 27847439; PMCID: PMC5106396.

11. Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001 Feb;15(2):163-9. doi: 10.1046/j.1365-2036.2001.00923.x. PMID: 11148433.

12. Arvola T, Laiho K, Torkkeli S, Mykkänen H, Salminen S, Maunula L, Isolauri E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999 Nov;104(5):e64. doi: 10.1542/peds.104.5.e64. PMID: 10545590.

13. Basu S, Chatterjee M, Ganguly S, Chandra PK. Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2007 Sep;41(8):756-60. doi: 10.1097/01.mcg.0000248009.47526.ea. PMID: 17700424.

14. Basu S, Chatterjee M, Ganguly S, Chandra PK. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial. J Paediatr Child Health. 2007 Dec;43(12):837-42. doi: 10.1111/j.1440-1754.2007.01201.x. Epub 2007 Sep 4. PMID: 17803667.

15. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J. 2003 Nov;5(11):767-9. PMID: 14650098.

16. Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007 Jan 15;25(2):177-84. doi: 10.1111/j.1365-2036.2006.03175.x. PMID: 17229242.

17. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child. 1995 Jan;72(1):51-3. doi: 10.1136/adc.72.1.51. PMID: 7717739; PMCID: PMC1510973.

18. Kekkonen RA, Sysi-Aho M, Seppanen-Laakso T, Julkunen I, Vapaatalo H, Oresic M, Korpela R. Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults. World J Gastroenterol. 2008 May 28;14(20):3188-94. doi: 10.3748/wjg.14.3188. PMID: 18506924; PMCID: PMC2712851.

19. Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, Korpela R, Meurman JH. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001 Nov-Dec;35(6):412-20. doi: 10.1159/000047484. PMID: 11799281.

20. Pessi T, Sütas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000 Dec;30(12):1804-8. doi: 10.1046/j.1365-2222.2000.00948.x. PMID: 11122221.

21. Piirainen L, Haahtela S, Helin T, Korpela R, Haahtela T, Vaarala O. Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy. Ann Allergy Asthma Immunol. 2008 Apr;100(4):338-42. doi: 10.1016/S1081-1206(10)60596-0. PMID: 18450119.

22. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol. 2004 Jul;114(1):131-6. doi: 10.1016/j.jaci.2004.03.036. PMID: 15241356.

23. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA, Kaila M, Isolauri E, Saxelin M, Arvilommi H, et al. Lactobacillus GG in acute diarrhea. Indian Pediatr. 1995 Oct;32(10):1140-2. PMID: 8984064.

24. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J. 1995 Feb;14(2):107-11. doi: 10.1097/00006454-199502000-00005. PMID: 7746691.

25. Vendt N, Grünberg H, Tuure T, Malminiemi O, Wuolijoki E, Tillmann V, Sepp E, Korpela R. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet. 2006 Feb;19(1):51-8. doi: 10.1111/j.1365-277X.2006.00660.x. PMID: 16448475.

26. Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr. 1999 Feb;18(1):43-50. doi: 10.1080/07315724.1999.10718826. PMID: 10067658.

27. Beausoleil M, Fortier N, Guénette S, L'ecuyer A, Savoie M, Franco M, Lachaine J, Weiss K. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007 Nov;21(11):732-6. doi: 10.1155/2007/720205. PMID: 18026577; PMCID: PMC2658588.

28. De Simone C, Ciardi A, Grassi A, Lambert Gardini S, Tzantzoglou S, Trinchieri V, Moretti S, Jirillo E. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol. 1992;14(1-2):331-40. doi: 10.3109/08923979209009228. PMID: 1597660.

29. Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. Efficacia dell' utilizzo del Lactobacilllus paracasei subsp. paracasei F19 nella vaginosi e nella prevenzione delle recidive di vaginite somministrato per via orale contemporaneamente ad un Lactobacillus acidofilusper via vaginale [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis]. Minerva Ginecol. 2006 Jun;58(3):227-31. Italian. PMID: 16783294.

30. Drago L, De Vecchi E, Nicola L, Zucchetti E, Gismondo MR, Vicariotto F. Activity of a Lactobacillus acidophilus-based douche for the treatment of bacterial vaginosis. J Altern Complement Med. 2007 May;13(4):435-8. doi: 10.1089/acm.2006.6040. PMID: 17532736.

31. Gaón D, Doweck Y, Gómez Zavaglia A, Ruiz Holgado A, Oliver G. Digestión de la lactosa por una leche fermentada con Lactobacillus acidophilus y Lactobacillus casei de origen humano [Lactose digestion by milk fermented with Lactobacillus acidophilus and Lactobacillus casei of human origin]. Medicina (B Aires). 1995;55(3):237-42. Spanish. PMID: 8544722.

32. Gaon D, Garmendia C, Murrielo NO, de Cucco Games A, Cerchio A, Quintas R, González SN, Oliver G. Effect of Lactobacillus strains (L. casei and L. Acidophillus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires). 2002;62(2):159-63. PMID: 12038039.

33. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst. 1980 Feb;64(2):255-61. doi: 10.1093/jnci/64.2.255. PMID: 6766508.

34. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, Kajimoto O, Fujiwara S. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci. 2005 Feb;88(2):527-33. doi: 10.3168/jds.S0022-0302(05)72714-4. PMID: 15653517.

35. Ishida Y, Nakamura F, Kanzato H, Sawada D, Yamamoto N, Kagata H, Oh-Ida M, Takeuchi H, Fujiwara S. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem. 2005 Sep;69(9):1652-60. doi: 10.1271/bbb.69.1652. PMID: 16195581.

36. Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004 Aug;23(4):467-75. doi: 10.1016/j.clnu.2003.12.002. PMID: 15297081.

37. Klein A, Friedrich U, Vogelsang H, Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr. 2008 May;62(5):584-93. doi: 10.1038/sj.ejcn.1602761. Epub 2007 Apr 18. PMID: 17440520.

38. Mustapha A, Jiang T, Savaiano DA. Improvement of lactose digestion by humans following ingestion of unfermented acidophilus milk: influence of bile sensitivity, lactose transport, and acid tolerance of Lactobacillus acidophilus. J Dairy Sci. 1997 Aug;80(8):1537-45. doi: 10.3168/jds.S0022-0302(97)76083-1. PMID: 9276791.

39. Onwulata CI, Rao DR, Vankineni P. Relative efficiency of yogurt, sweet acidophilus milk, hydrolyzed-lactose milk, and a commercial lactase tablet in alleviating lactose maldigestion. Am J Clin Nutr. 1989 Jun;49(6):1233-7. doi: 10.1093/ajcn/49.6.1233. PMID: 2499174.

40. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med. 1997 Mar 1;4(1):41-43. doi: 10.1111/j.1708-8305.1997.tb00772.x. PMID: 9815476.

41. Olek A, Woynarowski M, Ahrén IL, Kierkuś J, Socha P, Larsson N, Önning G. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study. J Pediatr. 2017 Jul;186:82-86. doi: 10.1016/j.jpeds.2017.03.047. Epub 2017 Apr 21. PMID: 28438377.

42. Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit. 2004 Nov;10(11):PI126-31. Epub 2004 Oct 26. PMID: 15507864.

43. Bejar W, Hamden K, Ben Salah R, Chouayekh H. Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe. 2013 Dec;24:4-11. doi: 10.1016/j.anaerobe.2013.08.006. Epub 2013 Aug 31. PMID: 23999246.

44. Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients. 2016 Mar 18;8(3):173. doi: 10.3390/nu8030173. PMID: 26999199; PMCID: PMC4808900.

45. Jeun J, Kim S, Cho SY, Jun HJ, Park HJ, Seo JG, Chung MJ, Lee SJ. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition. 2010 Mar;26(3):321-30. doi: 10.1016/j.nut.2009.04.011. Epub 2009 Aug 19. PMID: 19695834.

46. Nishimura M, Ohkawara T, Tetsuka K, Kawasaki Y, Nakagawa R, Satoh H, Sato Y, Nishihira J. Effects of yogurt containing Lactobacillus plantarum HOKKAIDO on immune function and stress markers. J Tradit Complement Med. 2015 Aug 21;6(3):275-80. doi: 10.1016/j.jtcme.2015.07.003. PMID: 27419093; PMCID: PMC4936756.

47. Iwasaki K, Maeda K, Hidaka K, Nemoto K, Hirose Y, Deguchi S. Daily Intake of Heat-killed Lactobacillus plantarum L-137 Decreases the Probing Depth in Patients Undergoing Supportive Periodontal Therapy. Oral Health Prev Dent. 2016;14(3):207-14. doi: 10.3290/j.ohpd.a36099. PMID: 27175447.

48. Liu TH, Chiou J, Tsai TY. Effects of Lactobacillus plantarum TWK10-Fermented Soymilk on Deoxycorticosterone Acetate-Salt-Induced Hypertension and Associated Dementia in Rats. Nutrients. 2016 May 2;8(5):260. doi: 10.3390/nu8050260. PMID: 27144579; PMCID: PMC4882673.

49. Kim JY, Kim H, Jung BJ, Kim NR, Park JE, Chung DK. Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation. Mol Cells. 2013 Feb;35(2):115-24. doi: 10.1007/s10059-013-2190-3. Epub 2013 Feb 21. PMID: 23456333; PMCID: PMC3887899.

50. L. T. Axelsson, T. C. Chung, W. J. Dobrogosz & S. E. Lindgren (1989) Production of a Broad Spectrum Antimicrobial Substance by Lactobacillus reuteri, Microbial Ecology in Health and Disease, 2:2, 131-136, DOI: 10.3109/08910608909140210

51. Sung V, D'Amico F, Cabana MD, Chau K, Koren G, Savino F, Szajewska H, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Tancredi D. Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20171811. doi: 10.1542/peds.2017-1811. PMID: 29279326.

52. Urbańska M, Gieruszczak-Białek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther. 2016 May;43(10):1025-34. doi: 10.1111/apt.13590. Epub 2016 Mar 16. PMID: 26991503.

53. Shornikova AV, Casas IA, Mykkänen H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997 Dec;16(12):1103-7. doi: 10.1097/00006454-199712000-00002. PMID: 9427453.

54. Athalye-Jape G, Rao S, Patole S. Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review. JPEN J Parenter Enteral Nutr. 2016 Aug;40(6):783-94. doi: 10.1177/0148607115588113. Epub 2015 Jun 9. PMID: 26059900.

55. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J. 2006;30(2):55-60. PMID: 16878680.

56. Dore MP, Bibbò S, Loria M, Salis R, Manca A, Pes GM, Graham DY. Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter. 2019 Dec;24(6):e12659. doi: 10.1111/hel.12659. Epub 2019 Sep 9. PMID: 31502382.

57. Spinler JK, Auchtung J, Brown A, Boonma P, Oezguen N, Ross CL, Luna RA, Runge J, Versalovic J, Peniche A, Dann SM, Britton RA, Haag A, Savidge TC. Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Infect Immun. 2017 Sep 20;85(10):e00303-17. doi: 10.1128/IAI.00303-17. PMID: 28760934; PMCID: PMC5607411.

58. Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol. 2008 Mar;104(3):672-80. doi: 10.1111/j.1365-2672.2007.03593.x. Epub 2007 Oct 9. PMID: 17927741.

59. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterology & Motility. 2011 Dec;23(12):1132-9.

60. Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R, Mastrojeni S, Malaguarnera G, Mistretta A, Volti GL, Galvano F. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Digestive diseases and sciences. 2012 Feb 1;57(2):545-53.

61. Yazawa K, Fujimori M, Amano J, Kano Y, Taniguchi SI. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer gene therapy. 2000 Feb;7(2):269.

62. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012 Oct;13(10):701.

63. Ahmed M, Prasad J, Gill H, Stevenson L, Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging. 2007 Jan-Feb;11(1):26-31. PMID: 17315077.

64. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7. doi: 10.1038/sj.ejcn.1600938. PMID: 10713750.

65. Caglar E, Kuscu OO, Selvi Kuvvetli S, Kavaloglu Cildir S, Sandalli N, Twetman S. Short-term effect of ice-cream containing Bifidobacterium lactis Bb-12 on the number of salivary mutans streptococci and lactobacilli. Acta Odontol Scand. 2008 Jun;66(3):154-8. doi: 10.1080/00016350802089467. PMID: 18568474.

66. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr. 2000 Nov;54(11):849-55. doi: 10.1038/sj.ejcn.1601093. PMID: 11114680.

67. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):288-92. doi: 10.1097/00005176-200403000-00011. PMID: 15076628.

68. Corrêa NB, Péret Filho LA, Penna FJ, Lima FM, Nicoli JR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005 May-Jun;39(5):385-9. doi: 10.1097/01.mcg.0000159217.47419.5b. PMID: 15815206.

69. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001 Dec;74(6):833-9. doi: 10.1093/ajcn/74.6.833. PMID: 11722966.

70. Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004 Aug;23(4):467-75. doi: 10.1016/j.clnu.2003.12.002. PMID: 15297081.

71. Klein A, Friedrich U, Vogelsang H, Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr. 2008 May;62(5):584-93. doi: 10.1038/sj.ejcn.1602761. Epub 2007 Apr 18. PMID: 17440520.

72. Matsumoto M, Benno Y. Anti-inflammatory metabolite production in the gut from the consumption of probiotic yogurt containing Bifidobacterium animalis subsp. lactis LKM512. Biosci Biotechnol Biochem. 2006 Jun;70(6):1287-92. doi: 10.1271/bbb.50464. PMID: 16794305.

73. Matsumoto M, Benno Y. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat Res. 2004 Dec 21;568(2):147-53. doi: 10.1016/j.mrfmmm.2004.07.016. PMID: 15542102.

74. Mohan R, Koebnick C, Schildt J, Mueller M, Radke M, Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res. 2008 Oct;64(4):418-22. doi: 10.1203/PDR.0b013e318181b7fa. PMID: 18552710.

75. Mohan R, Koebnick C, Schildt J, Schmidt S, Mueller M, Possner M, Radke M, Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol. 2006 Nov;44(11):4025-31. doi: 10.1128/JCM.00767-06. Epub 2006 Sep 13. PMID: 16971641; PMCID: PMC1698302.

76. Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, Stanley TV, Mitchell EA, Fitzharris P, Siebers R, Wu L, Crane J; Probiotic Study Group. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy. 2008 Oct;38(10):1606-14. doi: 10.1111/j.1365-2222.2008.03061.x. Epub 2008 Jul 2. Erratum in: Clin Exp Allergy. 2009 May;39(5):771. PMID: 18631345.

77. Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr. 2007 Apr;97(4):676-84. doi: 10.1017/S0007114507450292. PMID: 17349080.

78. Su P, Henriksson A, Tandianus JE, Park JH, Foong F, Dunn NW. Detection and quantification of Bifidobacterium lactis LAFTI B94 in human faecal samples from a consumption trial. FEMS Microbiol Lett. 2005 Mar 1;244(1):99-103. doi: 10.1016/j.femsle.2005.01.022. PMID: 15727827.

79. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. J Antimicrob Chemother. 2003 Aug;52(2):308-11. doi: 10.1093/jac/dkg346. Epub 2003 Jul 15. PMID: 12865387.

80. Wildt S, Munck LK, Vinter-Jensen L, Hanse BF, Nordgaard-Lassen I, Christensen S, Avnstroem S, Rasmussen SN, Rumessen JJ. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis. 2006 May;12(5):395-401. doi: 10.1097/01.MIB.0000218763.99334.49. PMID: 16670529.

81. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y, Yamashiro Y. Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int. 2004 Oct;46(5):509-15. doi: 10.1111/j.1442-200x.2004.01953.x. PMID: 15491374.

82. Simone M, Gozzoli C, Quartieri A, Mazzola G, Di Gioia D, Amaretti A, Raimondi S, Rossi M. The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. Biomed Res Int. 2014;2014:301053. doi: 10.1155/2014/301053. Epub 2014 Aug 28. PMID: 25309908; PMCID: PMC4163384.

83. Tabbers MM, de Milliano I, Roseboom MG, Benninga MA. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutr J. 2011 Feb 23;10:19. doi: 10.1186/1475-2891-10-19. PMID: 21345213; PMCID: PMC3048518.

84. Klemenak M, Dolinšek J, Langerholc T, Di Gioia D, Mičetić-Turk D. Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease. Dig Dis Sci. 2015 Nov;60(11):3386-92. doi: 10.1007/s10620-015-3769-7. Epub 2015 Jul 2. PMID: 26134988.

85. Okazaki T, Asahara T, Yamataka A, Ogasawara Y, Lane GJ, Nomoto K, Nagata S, Yamashiro Y. Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial. J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):46-50. doi: 10.1097/MPG.0000000000001140. PMID: 26859092.

86. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999 Summer;3(4):197-202. doi: 10.1016/s1201-9712(99)90024-3. PMID: 10575148.

87. Mullié C, Yazourh A, Thibault H, Odou MF, Singer E, Kalach N, Kremp O, Romond MB. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res. 2004 Nov;56(5):791-5. doi: 10.1203/01.PDR.0000141955.47550.A0. Epub 2004 Sep 3. PMID: 15347767.

88. Sekine K, Toida T, Saito M, Kuboyama M, Kawashima T, Hashimoto Y. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res. 1985 Mar;45(3):1300-7. PMID: 3971375.

89. Vivatvakin B, Kowitdamrong E. Randomized control trial of live Lactobacillus acidophilus plus Bifidobacterium infantis in treatment of infantile acute watery diarrhea. J Med Assoc Thai. 2006 Sep;89 Suppl 3:S126-33. PMID: 17718278.

90. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006 Jul;101(7):1581-90. doi: 10.1111/j.1572-0241.2006.00734.x. PMID: 16863564.

* These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease.

Warning Prop 65 for California Residents: This product may expose you to chemicals which are known to the State of California to cause cancer and birth defects or other reproductive harm. For more information, go to https://www.p65warnings.ca.gov/.

Search

Popular search terms: Whey Protein, Creatine, Multivitamin, CLA, TDEE Calculator, Nootropics, Burn Fat, Build Muscle, Energy